KALA
KALA BIO, Inc. · Healthcare
Orbimed Advisors LLC bought $3.2M of KALA BIO, Inc.
10% owner
Bought$3,192,710
$13.28Price
240,484Shares
+10%Stake
What KALA did for a copier
Prices for KALA after this filing aren't in yet.
Orbimed Advisors LLC's record
35 other buys with 3 months of prices since 2016: on average −12.5% against the S&P 500, and 12 of 35 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Wed, Jan 10. Filed Fri, Jan 12, 5:29 PM ET, after the close. Not investment advice.